SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC)

被引：2
|
作者：
Spiera, Robert [1 ]
Hummers, Laura [2 ]
Chung, Lorinda [3 ]
Frech, Tracy [4 ]
Domsic, Robin [5 ]
Hsu, Vivian [6 ]
Furst, Daniel [7 ,8 ]
Gordon, Jessica [1 ]
Mayes, Maureen [9 ]
Simms, Robert [10 ]
Lee, Elizabeth [11 ]
Constantine, Scott [11 ]
Dgetluck, Nancy [11 ]
White, Barbara [11 ]
机构：
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Johns Hopkins, Baltimore, MD USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Univ Utah, Salt Lake City, UT USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] Univ Med & Dent New Jersey, New Brunswick, NJ USA
[7] Pacific Arthrit Associates, Los Angeles, CA USA
[8] Univ Calif Los Angeles, Los Angeles, CA USA
[9] Univ Texas Houston, Houston, TX USA
[10] Boston Univ, Boston, MA 02215 USA
[11] Corbus Pharmaceut Inc, Norwood, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3390
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0325
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [41] Hepatic safety of ozanimod in relapsing multiple sclerosis in the DAYBREAK open-label extension study
    Selmaj, K.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Afsari, S.
    Shi, F.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 608 - 609
  • [42] SIMVASTATIN IN SYSTEMIC SCLEROSIS PATIENTS - AN OPEN-LABEL STUDY
    Ionitescu, S. C.
    Mihai, C.
    Bojinca, M.
    Sfrent-Cornateanu, R.
    Ion, A.
    Macovei, L.
    Manea, O.
    Sasu, M.
    Ancuta, I.
    Milicescu, M.
    Mogosan, C.
    Abobului, M.
    Berghea, F.
    Predeteanu, D.
    Ionescu, R.
    Stoica, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S158 - S158
  • [43] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL
    Khanna, D.
    Lin, C. J. F.
    Spotswood, H.
    Siegel, J.
    Furst, D.
    Denton, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 390 - 390
  • [44] Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from the Open-Label Period of a Phase 2 Randomized, Controlled Trial
    Khanna, Dinesh
    Denton, Christopher
    Spotswood, Helen
    Jahreis, Angelika
    van Laar, Jacob M.
    Burke, Laura
    Lin, Celia J. F.
    Pope, Janet E.
    Allanore, Yannick
    Mueller-Ladner, Ulf
    Siegel, Jeffrey
    Furst, Daniel E.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
    Spierings, Julia
    van Rhenen, Anna
    Welsing, Paco M. W.
    Marijnissen, Anne C. A.
    De Langhe, Ellen
    Del Papa, Nicoletta
    Dierickx, Daan
    Gheorghe, Karina R.
    Henes, Joerg
    Hesselstrand, Roger
    Kerre, Tessa
    Ljungman, Per
    van de Loosdrecht, Arjan A.
    Marijt, Erik W. A. F.
    Mayer, Miro
    Schmalzing, Marc
    Schroers, Roland
    Smith, Vanessa
    Voll, Reinhard E.
    Vonk, Madelon C.
    Voskuyl, Alexandre E.
    de Vries-Bouwstra, Jeska K.
    Walker, Ulrich A.
    Wuttge, Dirk M.
    van Laar, Jacob M.
    BMJ OPEN, 2021, 11 (03):
  • [46] A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of Anifrolumab in Adults with Systemic Lupus Erythematosus
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] Erratum to: Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis–related pulmonary artery hypertension and cutaneous vascular complications
    Uma Kumar
    Gokhale Sankalp
    V. Sreenivas
    Satbir Kaur
    Durgaprasanna Misra
    Rheumatology International, 2013, 33 (4) : 1053 - 1053
  • [48] Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications
    Kumar, Uma
    Gokhle, Sankalp S.
    Sreenivas, V.
    Kaur, Satbir
    Misra, Durgaprasanna
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (04) : 1047 - 1052
  • [49] An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
    Roger Hesselstrand
    Jörg H. W. Distler
    Gabriela Riemekasten
    Dirk M. Wuttge
    Marie Törngren
    Helén C. Nyhlén
    Fredrik Andersson
    Helena Eriksson
    Birgitta Sparre
    Helén Tuvesson
    Oliver Distler
    Arthritis Research & Therapy, 23
  • [50] An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
    Hesselstrand, Roger
    Distler, Joerg H. W.
    Riemekasten, Gabriela
    Wuttge, Dirk M.
    Torngren, Marie
    Nyhlen, Helen C.
    Andersson, Fredrik
    Eriksson, Helena
    Sparre, Birgitta
    Tuvesson, Helen
    Distler, Oliver
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
12345